• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃轻瘫主要症状指数日常日记的制定与内容效度。

Development and content validity of a gastroparesis cardinal symptom index daily diary.

机构信息

Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA.

出版信息

Aliment Pharmacol Ther. 2009 Sep 15;30(6):670-80. doi: 10.1111/j.1365-2036.2009.04078.x. Epub 2009 Jun 25.

DOI:10.1111/j.1365-2036.2009.04078.x
PMID:19558608
Abstract

BACKGROUND

The Gastroparesis Cardinal Symptom Index (GCSI) is a patient-reported outcome for gastroparesis using a two-week recall period. To minimize potential patient recall effects, a daily diary version of the GCSI (GCSI-DD) was developed.

AIMS

To evaluate the content validity of GCSI-DD for the symptoms in patients with documented gastroparesis, to capture symptom variability over time and to compare responses of this GCSI-DD to the original GCSI.

METHODS

In gastroparesis adults with delayed gastric emptying, cognitive debriefing interviews were conducted to elicit their perspective on relevant symptoms of gastroparesis and relevant recall periods and to evaluate patient understanding of GCSI-DD. Patients completed the GCSI-DD daily over a 2-week period and completed the GCSI at baseline and the 2-week follow-up visit.

RESULTS

Twelve gastroparesis patients, of whom five were diabetic and nine women, reported nausea (100%), vomiting (100%), stomach fullness (75%), bloating (58%) and loss of appetite (50%) were important symptoms. All patients understood diary instructions and item content and reported that the diary captured their gastroparesis symptom experience; 83% considered response scales adequate. There was significant daily variability in GCSI-DD scores. Mean GCSI-DD subscale and total scores over 2 weeks correlated strongly (all r > 0.90) with GCSI scores at 2-week follow-up.

CONCLUSIONS

The GCSI-DD includes symptoms relevant to patients with gastroparesis, captures daily variability of those symptoms and has psychometric properties consistent with a good patient-reported outcome endpoint for gastroparesis clinical trials.

摘要

背景

胃轻瘫综合症状指数(GCSI)是一种使用两周回顾期的胃轻瘫患者报告结局。为了最大程度地减少潜在的患者回忆效应,开发了 GCSI 的日常日记版本(GCSI-DD)。

目的

评估 GCSI-DD 对有记录的胃轻瘫患者症状的内容效度,捕捉随时间推移的症状变化,并比较该 GCSI-DD 与原始 GCSI 的反应。

方法

在患有胃排空延迟的胃轻瘫成年人中,进行认知性访谈,以了解他们对胃轻瘫相关症状和相关回顾期的看法,并评估患者对 GCSI-DD 的理解。患者在两周内每天完成 GCSI-DD,并在基线和两周随访时完成 GCSI。

结果

12 名胃轻瘫患者(其中 5 名为糖尿病患者,9 名为女性)报告恶心(100%)、呕吐(100%)、胃部饱满(75%)、腹胀(58%)和食欲不振(50%)是重要症状。所有患者都理解日记说明和项目内容,并报告说日记记录了他们的胃轻瘫症状体验;83%的患者认为反应量表足够。GCSI-DD 评分每天都有显著的变化。两周内 GCSI-DD 子量表和总分与两周随访时的 GCSI 评分高度相关(所有 r > 0.90)。

结论

GCSI-DD 包括与胃轻瘫患者相关的症状,可捕捉这些症状的日常变化,具有与胃轻瘫临床试验良好的患者报告结局终点相一致的心理测量特性。

相似文献

1
Development and content validity of a gastroparesis cardinal symptom index daily diary.胃轻瘫主要症状指数日常日记的制定与内容效度。
Aliment Pharmacol Ther. 2009 Sep 15;30(6):670-80. doi: 10.1111/j.1365-2036.2009.04078.x. Epub 2009 Jun 25.
2
Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD).评估胃轻瘫临床试验中的症状结局:胃轻瘫综合症状指数-日常日记(GCSI-DD)的有效性和反应性。
Neurogastroenterol Motil. 2012 May;24(5):456-63, e215-6. doi: 10.1111/j.1365-2982.2012.01879.x. Epub 2012 Jan 27.
3
Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms.胃轻瘫主要症状指数(GCSI):患者报告的胃轻瘫症状严重程度评估方法的制定与验证
Qual Life Res. 2004 May;13(4):833-44. doi: 10.1023/B:QURE.0000021689.86296.e4.
4
The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis.特发性或糖尿病性胃轻瘫患者中ANMS GCSI-DD的内容效度。
J Patient Rep Outcomes. 2018 Dec 13;2(1):61. doi: 10.1186/s41687-018-0081-2.
5
The American neurogastroenterology and motility society gastroparesis cardinal symptom index-daily diary (ANMS GCSI-DD): Psychometric evaluation in patients with idiopathic or diabetic gastroparesis.美国神经胃肠病学和动力学会胃轻瘫主要症状指数-日常日记(ANMS GCSI-DD):特发性或糖尿病性胃轻瘫患者的心理测量评估。
Neurogastroenterol Motil. 2019 Apr;31(4):e13553. doi: 10.1111/nmo.13553. Epub 2019 Feb 7.
6
Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary.多潘立酮治疗胃轻瘫的疗效:使用 GCSI 日常日记的前瞻性研究。
Neurogastroenterol Motil. 2018 Jan;30(1). doi: 10.1111/nmo.13246. Epub 2017 Nov 7.
7
[Validation of a Hebrew translation of the Gastroparesis Cardinal Symptom Index (GCSI)].[胃轻瘫主要症状指数(GCSI)希伯来语翻译的验证]
Harefuah. 2010 Feb;149(2):83-6, 125.
8
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.患者评估的胃轻瘫症状严重程度测量方法的开发与验证:胃轻瘫主要症状指数
Aliment Pharmacol Ther. 2003 Jul 1;18(1):141-50. doi: 10.1046/j.1365-2036.2003.01612.x.
9
Nausea predicts delayed gastric emptying in children.恶心可预测儿童的胃排空延迟。
J Pediatr. 2014 Jan;164(1):89-92. doi: 10.1016/j.jpeds.2013.09.019. Epub 2013 Oct 13.
10
Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis.临床试验:一项关于胃轻瘫患者经幽门内注射肉毒杆菌毒素的随机对照交叉研究。
Aliment Pharmacol Ther. 2007 Nov 1;26(9):1251-8. doi: 10.1111/j.1365-2036.2007.03467.x.

引用本文的文献

1
Prevalence of gastroparesis symptoms and its associated factors among type 2 diabetes mellitus patients in West Bank in Palestine: a national cross-sectional study.巴勒斯坦约旦河西岸2型糖尿病患者胃轻瘫症状的患病率及其相关因素:一项全国性横断面研究。
Front Med (Lausanne). 2025 Feb 12;12:1499725. doi: 10.3389/fmed.2025.1499725. eCollection 2025.
2
Whole Gut Motility Patterns in Patients with Chronic Nausea and Vomiting.慢性恶心和呕吐患者的全胃肠动力模式
J Clin Med. 2024 Nov 25;13(23):7127. doi: 10.3390/jcm13237127.
3
Evaluating Autoimmune Markers in Relation to Gastrointestinal Measures in Patients With Symptoms of Gastroparesis.
评估胃轻瘫症状患者自身免疫标志物与胃肠道指标的关系。
J Clin Gastroenterol. 2024 Aug 26. doi: 10.1097/MCG.0000000000002062.
4
Extensive scintigraphic gastric motor function testing with concurrent symptom recording predicts prospectively measured daily dyspeptic symptoms.广泛的闪烁胃动力功能测试与同步症状记录可预测前瞻性测量的每日消化不良症状。
Neurogastroenterol Motil. 2024 Aug;36(8):e14819. doi: 10.1111/nmo.14819. Epub 2024 May 30.
5
MRI-Based Quantification of Pan-Alimentary Function and Motility in Subjects with Diabetes and Gastrointestinal Symptoms.基于磁共振成像对糖尿病伴胃肠道症状患者全消化道功能和动力的量化分析
J Clin Med. 2023 Sep 14;12(18):5968. doi: 10.3390/jcm12185968.
6
A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis.一项随机、对照试验研究了大麻二酚在特发性和糖尿病性胃轻瘫中的疗效和安全性。
Clin Gastroenterol Hepatol. 2023 Dec;21(13):3405-3414.e4. doi: 10.1016/j.cgh.2023.07.008. Epub 2023 Jul 22.
7
Systemic Cytokine Expression in Diabetes Is Associated with Prolonged Gastrointestinal Transit Times and Cardinal Gastroparesis Symptoms.糖尿病中的全身细胞因子表达与胃肠道转运时间延长和主要胃轻瘫症状相关。
Biomedicines. 2023 Mar 27;11(4):1027. doi: 10.3390/biomedicines11041027.
8
Do prokinetic agents provide symptom relief through acceleration of gastric emptying? An update and revision of the existing evidence.促动力药物是否通过加速胃排空来缓解症状?对现有证据的更新和修订。
United European Gastroenterol J. 2023 Mar;11(2):146-162. doi: 10.1002/ueg2.12362. Epub 2023 Jan 30.
9
Using an Endoluminal Functional Lumen Imaging Probe (EndoFLIP™) to Compare Pyloric Function in Patients with Gastroparesis to Patients After Esophagectomy.使用腔内功能管腔成像探头(EndoFLIP™)比较胃轻瘫患者和食管切除术后患者的幽门功能。
J Gastrointest Surg. 2023 Apr;27(4):682-690. doi: 10.1007/s11605-022-05502-x. Epub 2022 Nov 14.
10
Evaluation of the safety profile of endoscopic pyloromyotomy by G-POEM: a French multicenter study.经胃内镜下幽门肌切开术(G-POEM)安全性的评估:一项法国多中心研究。
Therap Adv Gastroenterol. 2022 Oct 3;15:17562848221122472. doi: 10.1177/17562848221122472. eCollection 2022.